These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19389385)

  • 1. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
    Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
    Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.
    Zhou ZH; Rajabi M; Chen T; Karnaukhova E; Kozlowski S
    PLoS One; 2012; 7(10):e47296. PubMed ID: 23077587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.
    Hogwood J; Naggi A; Torri G; Page C; Rigsby P; Mulloy B; Gray E
    PLoS One; 2018; 13(3):e0193482. PubMed ID: 29494632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.
    Zhang Z; Weïwer M; Li B; Kemp MM; Daman TH; Linhardt RJ
    J Med Chem; 2008 Sep; 51(18):5498-501. PubMed ID: 18754653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
    Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
    J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.
    Adam A; Montpas N; Keire D; Désormeaux A; Brown NJ; Marceau F; Westenberger B
    Biomaterials; 2010 Aug; 31(22):5741-8. PubMed ID: 20427081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.
    Warkentin TE; Greinacher A
    Expert Opin Drug Saf; 2009 Mar; 8(2):129-44. PubMed ID: 19309242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
    Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.
    Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M
    Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
    McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study: contamination of heparin with oversulfated chondroitin sulfate.
    Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
    Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contaminated heparin associated with adverse clinical events and activation of the contact system.
    Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
    N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
    Bairstow S; McKee J; Nordhaus M; Johnson R
    Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides.
    Fonseca RJ; Oliveira SN; Pomin VH; Mecawi AS; Araujo IG; Mourão PA
    Thromb Haemost; 2010 May; 103(5):994-1004. PubMed ID: 20352164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from the contamination of heparin.
    Liu H; Zhang Z; Linhardt RJ
    Nat Prod Rep; 2009 Mar; 26(3):313-21. PubMed ID: 19240943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
    Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
    Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.